Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

Detalles Bibliográficos
Autores principales: Munshi, Mohammad, Junge, Alexandra, Gadaldi, Karolina, Yawalkar, Nikhil, Heidemeyer, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317694/
https://www.ncbi.nlm.nih.gov/pubmed/32613058
http://dx.doi.org/10.1016/j.jdcr.2020.05.014
_version_ 1783550684191260672
author Munshi, Mohammad
Junge, Alexandra
Gadaldi, Karolina
Yawalkar, Nikhil
Heidemeyer, Kristine
author_facet Munshi, Mohammad
Junge, Alexandra
Gadaldi, Karolina
Yawalkar, Nikhil
Heidemeyer, Kristine
author_sort Munshi, Mohammad
collection PubMed
description
format Online
Article
Text
id pubmed-7317694
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73176942020-06-30 Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine Munshi, Mohammad Junge, Alexandra Gadaldi, Karolina Yawalkar, Nikhil Heidemeyer, Kristine JAAD Case Rep Case Report Elsevier 2020-05-17 /pmc/articles/PMC7317694/ /pubmed/32613058 http://dx.doi.org/10.1016/j.jdcr.2020.05.014 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Munshi, Mohammad
Junge, Alexandra
Gadaldi, Karolina
Yawalkar, Nikhil
Heidemeyer, Kristine
Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
title Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
title_full Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
title_fullStr Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
title_full_unstemmed Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
title_short Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
title_sort ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317694/
https://www.ncbi.nlm.nih.gov/pubmed/32613058
http://dx.doi.org/10.1016/j.jdcr.2020.05.014
work_keys_str_mv AT munshimohammad ixekizumabfortreatmentofrefractoryacutegeneralizedexanthematouspustulosiscausedbyhydroxychloroquine
AT jungealexandra ixekizumabfortreatmentofrefractoryacutegeneralizedexanthematouspustulosiscausedbyhydroxychloroquine
AT gadaldikarolina ixekizumabfortreatmentofrefractoryacutegeneralizedexanthematouspustulosiscausedbyhydroxychloroquine
AT yawalkarnikhil ixekizumabfortreatmentofrefractoryacutegeneralizedexanthematouspustulosiscausedbyhydroxychloroquine
AT heidemeyerkristine ixekizumabfortreatmentofrefractoryacutegeneralizedexanthematouspustulosiscausedbyhydroxychloroquine

Ejemplares similares